Inducible nitric oxide synthase (iNOS) has been implicated in various central and peripheral pathophysiological diseases. Our high throughput screening initially identified a weak inhibitor of iNOS, thiocoumarin 13. From this lead, a number of potent derivatives were prepared that demonstrate favorable potency, selectivity and kinetics. Compound 30 has an IC50 of 60 nM for mouse iNOS and 185-fold and 9-fold selectivity for bovine eNOS and rat nNOS, respectively. In cellular assays for iNOS, this compound has micromolar potency. Furthermore, two compounds (16 and 30) demonstrate a reasonable pharmacokinetic profile in rodents. The synthesis, SAR, and biological activity of this novel class of compounds is described.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2005.02.036DOI Listing

Publication Analysis

Top Keywords

novel class
8
inducible nitric
8
nitric oxide
8
oxide synthase
8
design synthesis
4
synthesis characterization
4
characterization novel
4
class coumarin-based
4
coumarin-based inhibitors
4
inhibitors inducible
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!